Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 325.45
+16.70 (5.41%)
Feb 18, 2026, 1:36 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 118.12 billion as of February 17, 2026. Its market cap has decreased by -54.30% in one year.
Market Cap
118.12B
Enterprise Value
119.99B
Revenue
10.79B
Ranking
n/a
PE Ratio
131.40
Stock Price
325.45
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 118.12B, an increase of 350,345.35%. That is a compound annual growth rate of 294.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 118.12B | -41.59% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 293.40B |
| Emcure Pharmaceuticals | 282.22B |
| Wockhardt | 226.64B |
| Piramal Pharma | 220.36B |
| Eris Lifesciences | 195.93B |
| Alembic Pharmaceuticals | 151.33B |
| NATCO Pharma | 147.56B |
| Alivus Life Sciences | 112.89B |